Heart transplantation: approaching a new century
Related Experiment Video
Updated: Oct 23, 2026
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
1The Department of Cardiopulmonary Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston 77030, USA.
Insights
Heart transplantation offers hope for end-stage heart failure but faces donor shortages and serious complications like transplant vasculopathy. Future alternatives may reduce the need for donor hearts.
Area of Science:
- Cardiology
- Transplantation Medicine
- Surgical Innovation
Background:
- Heart transplantation has advanced significantly over 30 years.
- Donor heart scarcity remains a critical challenge, with demand exceeding supply.
- Transplant vasculopathy is the leading cause of death after the first year post-surgery.
Purpose of the Study:
- To review the current challenges and outcomes of heart transplantation.
- To highlight the persistent issues including donor organ shortage and post-operative complications.
- To discuss potential future alternatives to allogeneic heart transplantation.
Main Methods:
- Review of existing literature and clinical experience in heart transplantation.
- Analysis of perioperative mortality and long-term survival rates.
- Exploration of emerging technologies and therapeutic strategies for heart failure.
Main Results:
- Despite surgical experience, significant challenges persist, including donor organ scarcity.
- Perioperative mortality remains a concern for heart transplant recipients.
- Transplant vasculopathy, renal dysfunction, bleeding, infection, and rejection are major complications.
Conclusions:
- Heart transplantation is the optimal treatment for select end-stage heart failure patients.
- Addressing donor shortages and managing long-term complications are crucial.
- Mechanical cardiac support and novel medical therapies may offer future alternatives, potentially reducing reliance on donor hearts.
Abstract:
Although cardiac surgeons have gained considerable experience with heart transplantation during the past 30 years, this operation still presents many challenges. The number of transplant candidates continues to exceed the number of available donor hearts, and the shortage is not expected to improve. For patients fortunate enough to receive a donor heart, perioperative mortality is a serious concern. After the 1st postoperative year, the most frequent cause of death is transplant vasculopathy. Other potential complications include renal dysfunction, bleeding, infection, and allograft rejection. Despite these problems, heart transplantation remains the best hope for patients with end-stage heart failure that is unresponsive to conventional therapy. In the future, mechanical cardiac assistance and new medical treatments for end-stage heart disease may offer alternatives to heart transplantation, reducing the competition for scarce donor hearts.
